TABLE 5.
Cofactors by the rs2289669 polymorphism
| GG | GA | AA | |
|---|---|---|---|
| Sex (male) | 18 (50) | 22 (38) | 7 (33) |
| Age (years) | 75.3 ± 7.0 | 77.9 ± 6.5 | 75.6 ± 6.1 |
| A1C level before start (%) | 8.3 ± 0.9 | 8.3 ± 1.4 | 8.4 ± 1.1 |
| Prescribed metformin dose (mg) | 853 ± 476 | 662 ± 262 | 757 ± 320 |
| Sulfonylurea use (%) | 22 (61) | 33 (57) | 13 (62) |
| Change in sulfonylurea dose (DDD)* | −0.01 ± 0.53 | −0.17 ± 0.61 | −0.27 ± 0.52 |
| Time from diabetes diagnosis (years) | 5.5 ± 4.4 | 5.6 ± 4.8 | 4.7 ± 3.7 |
| Estimated glomerular filtration rate (ml/min) | 74 ± 19 | 68 ± 17 | 68 ± 14 |
| BMI (kg/m2) | 28.9 ± 3.9 | 28.1 ± 3.8 | 27.6 ± 3.2 |
Data are means ± SD or n (%).
P = 0.08 for trend. DDD, defined daily dose.